mgl-3196
Small moleculeexperimental
Clinical trial activity
12 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
9
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Jun 1, 2011 (NCT01367873)
Timeline
Indications
Approved for
Mechanism of action
THRB agonist
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)c1cc(Oc2c(Cl)cc(-n3nc(C#N)c(=O)[nH]c3=O)cc2Cl)n[nH]c1=O- Mol. weight
- 435.23 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral
- Availability
- Prescription Only
Oral
Yes
Parenteral
No
Topical
No
First in class
Sources
- ChEMBLCHEMBL3261331 ↗
Also known as
- 2-(3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl)-3,5-dioxo-2,3,4,5-tetrahydro(1,2,4)triazine-6-carbonitrile
- mgl-3196
- mgl-3196
- mgl-3196
- mgl-3196
- mgl-3196
- via-3196
- via-3196
- via-3196
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04671069 | Phase 1 | Jul 26, 2019 | Madrigal Pharmaceuticals |
| NCT03900429 | Phase 3 | Mar 28, 2019 | Madrigal Pharmaceuticals |
| NCT04671056 | Phase 1 | Nov 9, 2018 | Madrigal Pharmaceuticals |
| NCT04643795 | Phase 1 | Oct 24, 2018 | Madrigal Pharmaceuticals |
| NCT03413124 | Phase 1 | Feb 5, 2018 | Celerion, Madrigal Pharmaceuticals |
| NCT03220165 | Phase 1 | Aug 6, 2017 | Madrigal Pharmaceuticals, Worldwide Clinical Trials |
| NCT03038022 | Phase 2 | Feb 1, 2017 | Madrigal Pharmaceuticals |
| NCT02912260 | Phase 2 | Sep 1, 2016 | Madrigal Pharmaceuticals |
| NCT02749578 | Phase 1 | Apr 1, 2016 | Celerion, Madrigal Pharmaceuticals |
| NCT02542969 | Phase 1 | Sep 1, 2015 | Celerion, Madrigal Pharmaceuticals |
| NCT01519531 | Phase 1 | Jan 1, 2012 | Madrigal Pharmaceuticals |
| NCT01367873 | Phase 1 | Jun 1, 2011 | Madrigal Pharmaceuticals |
Showing 12 of 12 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Madrigal Pharmaceuticals | For profit | 12 | 12 | 3 | 2011 |
| Celerion | For profit | 3 | 0 | 1 | 2015 |
| Worldwide Clinical Trials | For profit | 1 | 0 | 1 | 2017 |
3 organizations
Page 1 / 1